Export Mendeley
＜Doctoral Thesis＞
Useful laboratory markers for the diagnosis of bone marrow involvement by malignant lymphoma
| Creator | |
|---|---|
| Examiner | |
| Language | |
| Academic Year Conferred | |
| Conferring University | |
| Degree | |
| Degree Type | |
| Publication Type | |
| Access Rights | |
| JaLC DOI | |
| Related DOI | |
| Abstract | INTRODUCTION:This study aimed to investigate the effect of bone marrow involvement by malignant lymphoma (BMI) on laboratory data and to determine the useful laboratory markers for diagnosing BMI. METH...ODS:We compared laboratory data between patients with and without BMI. We performed multivariate logistic regression and receiver operating characteristic (ROC) analyses to evaluate the diagnostic values of independent predictors. RESULTS:In the BMI group, platelets in peripheral blood (PLT) and megakaryocyte count in bone marrow (MgK) were significantly lower than those in the non-BMI group (PLT, P < .0001; MgK, P = .0384). The rate of peripheral blood involvement by malignant lymphoma (PBI), red blood cell distribution width (RDW), D-dimer (DD), soluble interleukin-2 receptor (sIL2R), aspartate aminotransferase (AST), and lactate dehydrogenase (LDH) was significantly higher in the BMI group than in the non-BMI group (PBI, P < .0001; RDW, P = .0190; DD, P = .0006; sIL2R, P < .0001; AST, P = .0256; LDH, P = .0002). In multivariate analysis, PBI, PLT, sIL2R, and MgK levels were independent predictors of BMI. CONCLUSION:PBI, PLT, sIL2R, and MgK may be the useful laboratory markers for BMI diagnosis.show more |
Hide fulltext details.
| File | FileType | Size | Views | Description |
|---|---|---|---|---|
med3082
|
243 KB | 484 | 本文 | |
|
med3082_abstract
|
58.6 KB | 1,349 | 要旨 | |
|
med3082_review
|
80.0 KB | 780 | 審査結果要旨 |
Details
| Record ID | |
|---|---|
| Peer-Reviewed | |
| Related PubMed ID | |
| Report Number | |
| Number of Diploma | |
| Granted Date | |
| Date Accepted | |
| Faculty | |
| Created Date | 2018.05.30 |
| Modified Date | 2020.01.31 |